Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4

Ruchao Peng(Institute of Microbiology), George F. Gao(Chinese Academy of Sciences), Zhiteng Li(University of Chinese Academy of Sciences), Ying Xu(University of Science and Technology of China), Yi Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Peng(Chinese Academy of Sciences), Jianxun Qi(Chinese Academy of Sciences), Peiyi Wang(Hefei University of Technology), Lianao Wu(Anhui University), Shaoshuai He(University of Chinese Academy of Sciences), Ying Wu(Chengdu Women's and Children's Central Hospital)
Proceedings of the National Academy of Sciences
August 29, 2019
10.1073/pnas.1909400116
Cited by 36

Related Papers

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
|Nature|2013|756